Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication

NCT01890135 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease
Intermittent Claudication

Interventions

DRUG: Zibotentan (ZD4054)
DRUG: placebo

Sponsor

University of Virginia

Collaborators

[object Object]